SkinMedica, Inc. Appoints Thomas Pletkovich National Sales Director and Announces 2011 Sales Force Expansion
Published: Aug 02, 2011
CARLSBAD, Calif., Aug. 2, 2011 /PRNewswire/ -- SkinMedica, the fastest growing professional skin care company in the United States, announced today that it has hired Thomas Pletkovich as National Sales Director. Mr. Pletkovich will lead the Company's newly expanded national sales force and report to Joe Willis, VP, Sales and Marketing.
Tom joins SkinMedica from OrthoDermatologics, a Johnson and Johnson company, where he led specialty, direct-sales teams in dermatology with a focus on treatments for photo damage and acne. Previously, he led sales and corporate accounts for OraPharma, another Johnson and Johnson company. Earlier, he held sales and government affairs management positions with GlaxoSmithKline.
"Tom brings SkinMedica extensive sales leadership experience and has an admirable track record in our market," commented SkinMedica President, Ted Schwarz. "We're very excited to welcome Tom as well as all of our new additions to the SkinMedica sales team. I am confident this new expansion will allow us to continue to cultivate successful practice partnerships and better meet the needs of our physician customers."
SkinMedica is expanding its sales force to 88 people, a 20 percent increase over 2010, which was also an expansion year. The Company has ranked fastest growing in its category for five consecutive years.
"I am very proud of the dynamic growth that our team consistently delivers, not just for SkinMedica, but for our practice partners," said Mary Fisher, CEO. "With performance consistently meeting or exceeding plan on both the top line and bottom line, we can invest with confidence in continued reliable growth."
Highly regarded among medical professionals, SkinMedica is known for its diverse product offering and efficacious formulas, namely the exclusive, highly-coveted growth factor blend TNS. The company's most recent launch, Redness Relief CalmPlex is the first and only non-prescription product clinically proven to reduce the appearance of visible redness in as little as two weeks.
SkinMedica, Inc. is focused on developing, acquiring and commercializing products that improve the appearance of skin. The Company markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The Company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum and hallmark TNS Recovery Complex®. The formulations in the Company's clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits.
SkinMedica's primary prescription product is VANIQA® (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the reduction of unwanted facial hair in women.
SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com.
TNS Recovery Complex®, VANIQA®, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.
SOURCE SkinMedica, Inc.